Background: Infection and capsular contracture are two of the most significant complications of breast-implant surgery. Both complications are associated with bacterial contamination of the implant surface. Plasma activation of the surface of a silicone breast implant changes its surface properties from water repelling (hydrophobic) to water absorbing (hydrophilic), thus making it possible for antibacterial irrigants to temporarily adsorb onto the implant surface. Objectives: To support our hypothesis that by changing the surface properties we could render antibacterial irrigation more effective in inhibiting bacterial growth on a breast implant shell. Methods: An in vitro study using silicone discs cut from a textured silicone breast implant shell was performed by treating some of the discs with plasma activation and then exposing the discs to contamination with either Staphylococcus aureus or Pseudomonas aeruginosa and then variously treating the discs with 10% povidone iodine, Cefazolin, or Gentamicin. Bacterial contamination was verified and counted using contact plates as well as culture media. Results: Plasma activation changed the wetting properties of the disc's surface from hydrophobic to hydrophilic. Nonplasma activated contaminated discs demonstrated clear bacterial growth both in the untreated group and in the antibacterial-treated group. Combining antibacterial treatment with plasma activation resulted in complete inhibition of bacterial growth in each of the groups treated with antibacterial irrigants. Conclusions: Combining plasma activation with topical antibacterial irrigants can inhibit the growth of bacteria on implant shell discs. By changing the properties of the surface from hydrophobic to hydrophilic, the adsorption of the antibacterial irrigants is enhanced.
Whenever an implantable medical device is inserted into the body, whether it is a pacemaker, an artificial joint, or a breast implant, one of the overriding concerns related to the function of that device is the avoidance of infection. If the surface of the device becomes contaminated and/ or colonized with bacteria, it is very difficult for the host defense mechanisms to clear the bacteria from the surface of the implant, which can lead to outright infection necessitating implant removal. This observation is highlighted by the results of clinical studies showing infection occurring in 7% to 24% of women following implant-based breast reconstruction and up to 2% of women following breast augmentation. [1] [2] [3] [4] [5] However, outright infection necessitating implant removal is not necessarily the final outcome of implant contamination. Capsular contracture is one of the most common complications associated with the use of breast implants [6] [7] [8] and recent theories concerning the etiology of capsular contracture have focused on the presence of a subclinical infection, where the bacteria exist together in a symbiotic relationship with the host by secreting a glycoprotein matrix that allows the bacteria to function, thrive, and propagate in what has been referred to as a biofilm. 9, 10 Although biofilm biology is complex and multifactorial, it is postulated that the glycoprotein matrix is thought to shield the bacteria from the host's normal defense mechanisms leading to chronic inflammation 11, 12 with subsequent contraction of the surrounding capsule. [13] [14] [15] Nevertheless, glycoprotein is just one of several complex defense mechanisms that biofilms may employ. [11] [12] [13] [14] [15] A natural solution for the prevention of breast implant contamination and the potential reduction in both infection and capsular contracture rates involves the use of antibacterial irrigants. To this end, several studies have documented improved results using either a single or a triple antibacterial irrigation strategy designed to reduce the potential for implant contamination at the time of breast implant placement. 16 One limiting factor associated with the use of antibacterial irrigants is related to the hydrophobic properties displayed by the shell of the breast implant. As a result of the hydrophobicity of the implant surface, fluid simply runs off the device and very little of the actual antibacterial irrigant remains associated with the implant surface for any period of time and most likely is quickly washed away during the procedure. Therefore, most of the effect of the antibiotic irrigation is either reduced or lost completely. 17 The hydrophobic water repelling properties of the surface of a silicone implant shell are present because all the molecules in the polymer are securely bound within the polymer matrix, which renders the surface "closed" to new chemical interactions. By applying energized Argon gas onto the implant surface, the binding energy of the closed polymer matrix can be overcome allowing -OH reactive species to temporarily bind to the silicone molecules located in the outer nanometric layer. These -OH species have a high electric polarity that attracts polar liquids such as water. As a result, the treated surface becomes profoundly hydrophilic, or water adsorbing, and demonstrates enhanced "wetting" properties. This effect is termed "plasma activation" and the technology has been previously studied in several different reports involving dental implants (Figure 1 ). [18] [19] [20] [21] The purpose of this study was to document the effect of plasma activation on the surface of a textured silicone implant shell and determine what effect subsequent antibacterial irrigation of treated and untreated surfaces would have on bacterial growth after contamination with two bacterial strains commonly associated with implant infections. It is hypothesized that enhancing the "wetting" properties of an implant surface by using plasma activation technology would make topical antibacterial irrigation more effective which would lead to an inhibition of bacterial growth.
METHODS
The study took place at our clinical microbiology laboratory, from December 2015 to March 2016. The textured round silicone gel filled implant used in our study had an imprint technique using polyurethane foam pressed into an incompletely cured implant shell to create a roughened surface (Siltex texturing, Mentor, Dallas, TX). This implant was the source material to provide 5 mm round discs that were cut from the implant shell. The gel residue was removed from the inner shell lining and the discs were autoclaved for sterilization. The textured surface device was specifically chosen due to the fact that the complicated surface topography of the discs would present a maximum challenge for the plasma activation process to be realized.
The plasma treated silicone discs underwent activation by placing each disc under a radiofrequency electrode in a closed chamber containing flowing argon gas (Active-Si device, Nova Plasma, Megiddo, Israel). The textured surface side of each disc was activated at 13 watts for 30 seconds, which is a treatment time and intensity that has been previously shown to produce the desired effect. After activation, the surface properties of the textured surface side of the treated discs changed from hydrophobic to hydrophilic, resulting in a uniform "wetting" of the textured surface side of the disc (Figure 2 ).
Clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa that had been recovered from breast implant infections served as the bacterial pathogens used to contaminate the silicone discs. The antibacterial irrigants selected for the study included 10% povidone-iodine solution (Vitamed Pharmaceutical Industries, Israel) and Cefazolin (Teva Pharmaceutical Industries, Israel) used to treat discs contaminated with S. aureus, and Gentamicin (Teva Pharmaceutical Industries, Israel) used to treat discs contaminated with P. aeruginosa. The susceptibilities of the two clinical strains to the specific antibacterial were assessed in vitro prior to the study and interpreted according to Clinical and Laboratory Standards Institute (CLSI) breakpoints. 22 The minimal inhibitory concentration (MIC) of the P. aeruginosa isolate to Gentamicin was 4 mg/L and the MICs of the S. aureus isolate to penicillin and to Cefazolin were 0.06 mg/L and 1 mg/L, respectively.
After plasma activation, each of the discs was sorted into those that would be treated with antibacterial irrigants and those that would be treated with sterile normal saline. In both instances, the disc was immersed in the respective solution for 5 seconds and the excess fluid was gently removed. To create a bacterial source to contaminate the discs, 10 µL drops from an overnight culture of 1 × 10 5 cfu/mL S. aureus or P. aeruginosa were applied on 5% blood agar plates (Hy Laboratories, Israel) and left to briefly dry in a sterile environment. Each drop contained approximately 1 × 10 3 cfu/mL. Each disc was then individually rubbed over a separate spot of the contaminated agar plate in a circular motion using sterile tweezers, 5 rotations to the right and 5 rotations to the left, in order to obtain an equal amount of bacteria on each disc. This technique of disc contamination was specifically chosen in an attempt to duplicate the real manner in which a breast implant rubs against the skin and the tissue as the implant is positioned into the breast pocket.
Experiment 1: A Semiquantitative Assay of Disc Contamination With Bacteria
In this experiment, we performed a semiquantitative assay designed to assess the ability of the bacteria to adhere to the discs, and the effect of antibiotic irrigation with and without plasma activation. Eight of the prepared discs were chosen and divided into four groups with two discs in each group: 1 -control disc with no plasma activation and no irrigant; 2 -disc with no plasma activation but soaked in Cefazolin; 3 -plasma activated disc soaked in saline; 4 -plasma activated disc soaked in Cefazolin. All the discs were contaminated as described with S. aureus, and then plated onto tryptic soy agar contact plates with lecithin and tween (Hy Laboratories, Israel), by touching the contaminated textured surface of the disc onto the sterile plate. The plates were then incubated at 37°C and the bacterial load was evaluated by colony counts after 24 hours.
Experiment 2: A Quantitative Analysis of Disc Contamination With Bacteria Over Time
In this experiment, we performed a quantitative analysis of bacterial contamination in the different study groups. Each contaminated disc was incubated in a sterile 2 mL tube containing 10% brain-heart infusion (BHI, Hy Laboratories, Israel) in normal saline at 37°C without shaking, and bacteria were allowed to colonize the surface of the discs for 4, 9, and 14 days. We used BHI medium that is a rich medium in order to ensure optimal nutritional conditions for bacterial recovery from the silicon shell surface. These conditions enabled us to evaluate the actual effect of plasma treatment on bacterial viability without introducing an additional factor that could interfere with bacterial recovery.
The intent of this study was to determine the early effect of the treatment, therefore no evaluation past 14 days was included in the protocol. At each time point, discs were removed from the culture medium and sonicated for 5 minutes in a sonication bath in order to detach the bacteria from the silicone discs. 23 The samples were then diluted and the bacteria were enumerated by viable counts performed on Mueller-Hinton agar plates (Hy Laboratories). The plates were incubated at 37°C for 24 hours prior to colony count. Using this protocol, two groups of discs were studied:
Group 1
Each of the discs was contaminated with S. aureus and then divided into two arms including nonactivated and plasma activated discs. The nonactivated discs were further divided into a no irrigant subgroup, and one subgroup irrigated with 10% povidone-iodine, and one subgroup irrigated with Cefazolin. The activated discs were divided into two subgroups, one treated with 10% povidone-iodine and one treated with Cefazolin.
Group 2
Each of the discs was contaminated with P. aeruginosa and then divided into two arms including nonactivated and plasma activated discs. The nonactivated discs were divided into a no irrigant subgroup and a subgroup treated with Gentamicin. The activated discs were isolated into one subgroup treated with Gentamicin. In each instance for both groups 1 and 2, there were two discs evaluated in each subgroup (Figure 3 ).
Experiment 3: Direct Visualization of Contaminated Discs
In this experiment, we performed direct visualization of the discs contaminated with P. aeruginosa on day 14 with fluorescence microscopy, using a LIVE/DEAD BacLight Bacterial Viability Kit L7007 (Molecular Probes, OR) according to the manufacturer's instructions. Threedimensional images were obtained with live bacteria being visualized with a green color and dead bacteria showing as red. The microscopic analysis was performed using a confocal Zeiss LSM 510 META microscope with X40 immersion lens magnification (Carl Zeiss Microscopy GmbH, Oberkuchen, Germany). Three subgroups were studied: nonplasma activated disc with no irrigation; nonplasma activated disc treated with Gentamicin; and plasma activated disc treated with Gentamicin.
Statistical Analysis
Statistical analysis was performed with IBM SPSS Statistics software. Bacterial counts were evaluated using a one-way analysis of variance (ANOVA). Significant differences were regarded as P < 0.05.
RESULTS
Experiment 1 showed that bacterial growth did occur and was most prominent with the untreated control discs, and less so with the untreated discs irrigated with Cefazolin. In the discs that underwent plasma activation, no bacterial growth was noted with and without Cefazolin irrigation (Table 1) .
Experiment 2 showed that in the S. aureus group, the nonplasma activated discs all demonstrated 10 6 to 10 8 cfu at time points day 4, 9, and 14 for the untreated discs as well as the povidone-iodine and Cefazolin treated discs. In the povidone-iodine subgroup, no further colony forming units were identified at day 9 and 14. For the plasma activated discs, the addition of povidone iodine and Cefazolin resulted in no colony forming units being noted at any time point (Figure 4 ). In the P. aeruginosa group, again the nonplasma activated discs demonstrated 10 6 to 10 8 cfu at time point's day 4, 9, and 14 for the untreated discs as well as the Gentamicin treated discs. For the plasma-activated discs treated with Gentamicin, roughly 10 4 cfu were noted at day 4, which then dropped to zero at days 9 and 14 ( Figure 5 ). Experiment 3 showed abundant bacterial growth on the nonplasma activated disc that was not treated with any irrigant as demonstrated by fluorescence microscopy with the viable bacteria stained in green ( Figure 6A ). In the nonplasma activated disc treated with Gentamicin, viable bacteria were again detected however in reduced numbers ( Figure 6B ). In the plasma-activated disc treated with Gentamicin, no viable bacteria were observed ( Figure 6C ).
DISCUSSION
Bacterial infection continues to be a major complication of breast implant surgery. [1] [2] [3] [4] [5] The treatment of these types of infections is challenging due to bacterial contamination and biofilm formation on the breast implant. [9] [10] [11] [12] Clearance of bacteria from the colonized implant surface is difficult to accomplish with the end result being at best, a chronic inflammatory response leading to capsular contracture and at worst, outright infection necessitating removal of the implant. A common practice to limit the potential for contamination of the implant is to immerse it in an antibacterial solution prior to implantation. 16, 24, 25 In reality, however, the hydrophobic water repelling properties of the surface of the silicone implant do not allow the antibiotic to be effectively distributed and retained on the implant surface and therefore the effectiveness of any antibacterial irrigant is limited.
This study was designed to test the effectiveness of a new antibacterial strategy related to the use of breast implants that focuses on altering the surface properties of the implant such that a hydrophilic or water absorbing surface is created that prolongs the presence of an antibacterial on the surface of the implant by means of plasma activation technology. Plasma technology is widely employed in the modification of the surface properties of polymer materials, and several medical uses have been described. Giro et al 19 exposed titanium dental implants to a plasma process just before implantation in a canine model and evaluated the bone integration into the titanium. After a healing period of 3 weeks, the bone-to-implant contact was significantly higher in the plasma-treated group than in the control group. In this study, we demonstrated for the first time on silicone breast implant shell discs that plasma activation increases wettability, and converts surface properties from hydrophobic to hydrophilic (Figure 1 ). Our hypothesis was that plasma activation of the silicone shell surface prior to immersion in an antibacterial irrigant could increase the ability of the irrigant to attach uniformly onto the implant's surface and therefore prevent bacterial growth much more effectively.
The findings of our current in vitro study support this hypothesis. In experiment 1, implant discs not treated with plasma activation that had been contaminated with S. aureus and then exposed to Cefazolin showed bacterial growth on contact plates, while the combination of plasma activation and Cefazolin treatment resulted in no bacterial growth whatsoever (Table 1) .
Interestingly, discs that were treated solely with plasma activation and then exposed to normal saline also showed no bacterial growth. This was an unexpected finding that could suggest that plasma activation alone might make it more difficult for bacteria to adhere creating a situation where any bacteria that are present would more or less remain in a planktonic state. Previous studies demonstrated that hydrophilic surfaces, compared to hydrophobic ones, allow fewer inflammatory cells and bacteria to adhere to them, promote the apoptosis of adherent inflammatory cells, promote a cytokine profile that promotes wound healing, and reduce the denaturing of proteins causing an inflammatory response. [9] [10] [11] [12] [26] [27] [28] The inference would then be that simple plasma activation alone might prevent bacterial adherence and thus be used as a treatment modality to reduce the chances for biofilm formation as well as infection regardless of the use of an antibacterial irrigant. However, it was also noted during the preparation of the discs that, after plasma activation, the adherence of the gel from the agar plates used to contaminate the discs was less tenacious and the plasma activated discs were less "sticky." It appeared that the disc surface exhibited more lubricity, which may have hindered the ability of the bacteria to adhere. These findings will require additional study to determine the exact effect that plasma activation alone may have on bacterial adherence.
The positive effect of plasma activation used in conjunction with an antibacterial irrigant was further demonstrated by the results of experiment 2. Here, quantitative growth of both strains of bacteria was shown to be vigorous and roughly equal at days 4, 9, and 14 in nonplasma activated Bacterial growth was evaluated semi-quantitatively using the following scale: (++) confluent, (+) medium, and (-) none.
control discs, both with no antibacterial irrigant treatment, or with Cefazolin and Gentamicin treatment (Figures 4-5) . In other words, exposing the nonplasma activated discs to antibacterial solutions did not hinder bacterial growth, with exception to treatment with 10% povidone-iodine that significantly reduced bacterial growth. Conversely, in plasma activated discs treated with 10% povidone-iodine and Cefazolin, no growth was noted from day 4 on, and in the Gentamicin treated discs, growth was diminished at day 4 and absent at days 9 and 14 ( Figures 4-5) .
Here, exposure of the discs to the antibacterial solutions did have an effect that was immediate in the S. aureus strain, and slightly delayed with the P. aeruginosa strain. The differences in bacterial enumeration following plasma activation between S. aureus and P. aeruginosa ( Figures  4-5 ) may be explained by inter-species variations between these two pathogens, that may be due to differences in adhesion properties of each species. Surprisingly, in the nonplasma activated discs treated with 10% povidone-iodine, growth was diminished slightly at day 4 and absent at day 9 and 12. It may well be that the unique properties of the iodine solution may allow it to exhibit some level of surface adherence leading to an antibacterial effect without the need for surface activation as occurs with the plasma technology. Interestingly, the first early reports of reducing the incidence of capsular contracture with an antibacterial irrigant used povidone-iodine as the irrigant of choice. 29 It is possible that the variable of surface adherence may play a role in these findings.
The findings on fluorescence microscopy also supported these results as the nonplasma activated contaminated discs showed a vigorous live P. aeruginosa layer formed on the disc's surface after 14 days ( Figure 6A ). In the nonplasma activated discs treated with Gentamicin, the number of bacteria identified on the disc surface was reduced ( Figure 6B ). Combining plasma activation with Gentamicin treatment, however, resulted in the complete absence of live bacteria on the discs' surfaces ( Figure 6C) . Direct microscopy visualization supported the bacterial quantitation results and further demonstrated the superiority of plasma activation prior to antibacterial irrigation in bacterial growth inhibition. Limitations of this current study include a relatively small sample size, and the use of implant discs and not intact implants. In addition, the contamination and treatment techniques in our in vitro model are artificial, and do not precisely imitate the true infection process in implantbased surgeries.
Taken together, the results of this study demonstrate the additive ability of plasma activation used in conjunction with antibacterial irrigants to inhibit bacterial growth on silicone discs contaminated with either Gram-negative or Gram-positive bacteria. These results may serve as the first steps in forming a new concept in the prevention of bacterial biofilm formation in implant-based surgery. By changing the properties of the implant surface from hydrophobic to hydrophilic, the adsorption of water-based antibacterials on the implant surface improves their effectiveness in preventing bacterial contamination, and by inference, biofilm formation, and infection.
The hydrophilic effect of plasma activation is transitory and depends on the environment surrounding the implant. In a dry atmospheric environment, the hydrophilicity fades after a few days. In a polar liquid environment, it may last for months. Therefore, the effects noted here would be effective against only early bacterial contamination. This is certainly directly analogous to the clinical situation as most early implant contamination occurs at the time of insertion. However, these results cannot be used to draw conclusions regarding the development of late infection or capsular contracture, and further in vivo experimental models for capsular contracture are indicated.
Moreover, this study represents a preliminary investigation of this technology. Further research will be directed at investigating the effect on different types of implant surfaces, both smooth and textured, as well as examining the effect of plasma activation alone in addition to combining plasma activation with different antibacterial irrigants and on additional strains of bacteria. Different implant texturing effects the surface topography and wettability, leading to different biomaterial characteristics. [26] [27] [28] Rougher surfaces have higher hydrophobicity with increased contact angle. [26] [27] [28] Topographically, the texturing difference is at the micrometric level, while the plasma activation process is at the nanometric level, allowing it to be effective on various types of surface texturing. [18] [19] [20] [21] Another concern with this type of biomaterial study is the effect of the plasma treatment on the silicone polymer. Preliminary tests including Fourier transform infrared spectroscopy, differential scanning calorimetry, and density were performed and showed no permanent change to the silicone implant shell after plasma activation. Further full-sized breast implant biocompatible and mechanical studies are required to determine the safety of the plasma technology on the integrity of the silicone implant.
CONCLUSIONS
Combining plasma activation with antibacterial irrigants can inhibit the growth of bacteria on a textured silicone rubber breast implant shell. By changing the properties of the implant shell from hydrophobic to hydrophilic, the adsorption of the antibacterial irrigants is enhanced. Further studies examining the effect of plasma technology alone and combination with other types of implant shells and with other antibacterial irrigants targeting different bacterial strains are indicated.
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